$CHEK
Check-Cap Ltd Stock $chek

$chek Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000117891323001275 Filed on March 31, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.259M	$5.647M	$1.452M
YoY Change	-13.29%	14.4%	32.0%
% of Gross Profit
Research & Development	$2.956M	$14.27M	$4.126M
YoY Change	-28.36%	17.17%	45.8%
% of Gross Profit
Depreciation & Amortization	$150.0K	$404.0K	$66.00K
YoY Change	127.27%	97.07%	65.0%
% of Gross Profit
Operating Expenses	$4.215M	$14.27M	$5.578M
YoY Change	-24.44%	-17.61%	41.93%
Operating Profit		-$20.03M
YoY Change		15.66%
Interest Expense	$502.0K	$12.00K	$101.0K
YoY Change	397.03%	-87.63%	405.0%
% of Operating Profit
Other Income/Expense, Net		$926.0K
YoY Change		4109.09%
Pretax Income	-$3.713M	-$19.11M	-$5.477M
YoY Change	-32.21%	11.08%	40.08%
Income Tax
% Of Pretax Income
Net Earnings	-$3.713M	-$19.11M	-$5.477M
YoY Change	-32.21%	11.08%	40.08%
Net Earnings / Revenue
Basic Earnings Per Share		$3.37
Diluted Earnings Per Share	-$0.63	$3.37	-$56.75K
COMMON SHARES
Basic Shares Outstanding	5.844M shares	5.672M shares
Diluted Shares Outstanding		5.672M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.70M	$41.70M	$51.56M
YoY Change	-19.13%	-19.13%	189.99%
Cash & Equivalents	$4.090M	$4.090M	$26.46M
Short-Term Investments	$37.61M	$37.61M	$25.10M
Other Short-Term Assets	$223.0K	$931.0K	$1.189M
YoY Change	-81.24%	-5.29%	85.78%
Inventory
Prepaid Expenses	$260.0K		$470.0K
Receivables
Other Receivables
Total Short-Term Assets	$42.63M	$42.63M	$52.75M
YoY Change	-19.18%	-19.18%	186.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.751M	$2.811M	$2.909M
YoY Change	-39.81%	-3.37%	138.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$2.811M	$2.811M	$2.909M
YoY Change	-3.37%	-3.37%	138.44%
TOTAL ASSETS
Total Short-Term Assets	$42.63M	$42.63M	$52.75M
Total Long-Term Assets	$2.811M	$2.811M	$2.909M
Total Assets	$45.44M	$45.44M	$55.66M
YoY Change	-18.36%	-18.36%	183.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$952.0K	$952.0K	$1.050M
YoY Change	-9.33%	-9.33%	22.09%
Accrued Expenses	$1.598M	$1.598M	$2.311M
YoY Change	-30.85%	-30.85%	30.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.408M	$3.408M	$4.041M
YoY Change	-15.66%	-15.66%	35.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$721.0K	$721.0K	$927.0K
YoY Change	-22.22%	-22.22%	231.07%
Total Long-Term Liabilities	$721.0K	$721.0K	$927.0K
YoY Change	-22.22%	-22.22%	231.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.408M	$3.408M	$4.041M
Total Long-Term Liabilities	$721.0K	$721.0K	$927.0K
Total Liabilities	$4.129M	$4.129M	$4.968M
YoY Change	-16.89%	-16.89%	52.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.3M		-$108.2M
YoY Change	17.66%
Common Stock	$83.66M		$68.79M
YoY Change	21.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.31M	$41.31M	$50.69M
YoY Change
Total Liabilities & Shareholders Equity	$45.44M	$45.44M	$55.66M
YoY Change	-18.36%	-18.36%	183.4%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$3.713M	-$19.11M	-$5.477M
YoY Change	-32.21%	11.08%	40.08%
Depreciation, Depletion And Amortization	$150.0K	$404.0K	$66.00K
YoY Change	127.27%	97.07%	65.0%
Cash From Operating Activities	-$4.147M	-$18.71M	-$4.384M
YoY Change	-5.41%	15.02%	25.62%
INVESTING ACTIVITIES
Capital Expenditures	$91.00K	$486.0K	-$263.0K
YoY Change	-134.6%	-148.31%	192.22%
Acquisitions
YoY Change
Other Investing Activities	-$1.022M	-$12.02M	-$8.300M
YoY Change	-87.69%	-19.85%	-268.36%
Cash From Investing Activities	-$1.113M	-$12.51M	-$8.563M
YoY Change	-87.0%	-21.85%	-276.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$203.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$8.850M	-203.0K
YoY Change	-100.0%	-82.66%
NET CHANGE
Cash From Operating Activities	-4.147M	-$18.71M	-4.384M
Cash From Investing Activities	-1.113M	-$12.51M	-8.563M
Cash From Financing Activities	0.000	$8.850M	-203.0K
Net Change In Cash	-5.260M	-$22.37M	-13.15M
YoY Change	-60.0%	-219.25%	-1066.91%
FREE CASH FLOW
Cash From Operating Activities	-$4.147M	-$18.71M	-$4.384M
Capital Expenditures	$91.00K	$486.0K	-$263.0K
Free Cash Flow	-$4.238M	-$19.19M	-$4.121M
YoY Change	2.84%	25.79%	21.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001610590
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-36848
CY2022	dei	Entity Registrant Name EntityRegistrantName	Check-Cap Ltd.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Check-Cap Building
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	29 Abba Hushi Avenue
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 1271
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Isfiya
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3009000
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Security12b Title Security12bTitle	Ordinary Shares
CY2022	dei	Trading Symbol TradingSymbol	CHEK
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5844463	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	1197
CY2022	dei	Auditor Name AuditorName	Brightman Almagor Zohar & Co.
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4090000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26457000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	352000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	350000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	37609000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	25104000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	579000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	839000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	42630000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	52750000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1751000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1793000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1060000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1116000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2811000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2909000	usd
CY2022Q4	us-gaap	Assets Assets	45441000	usd
CY2021Q4	us-gaap	Assets Assets	55659000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	952000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1050000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	802000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	680000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1261000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1961000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	337000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	350000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	56000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3408000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4041000	usd
CY2022Q4	chek	Royalties Provision RoyaltiesProvision	94000	usd
CY2021Q4	chek	Royalties Provision RoyaltiesProvision	132000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	627000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	795000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	721000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	927000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5844463	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5844463	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4840089	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4840089	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	83664000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	68787000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84941000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90089000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127293000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108185000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41312000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50691000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45441000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55659000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14271000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12349000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10008000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5763000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4972000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3924000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-20034000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-17321000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13932000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	926000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	119000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	86000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13846000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19108000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17202000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13846000	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.37
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.37
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.14
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.14
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.01
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5671786	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5671786	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4159870	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4159870	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1537060	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	1537060	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	6234000	usd
CY2020	chek	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	4731000	usd
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1361000	usd
CY2020	chek	Stock And Warrant Issued During Period Value In Financing StockAndWarrantIssuedDuringPeriodValueInFinancing	10139000	usd
CY2020	chek	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction	920000	usd
CY2020	chek	Stock And Warrants Issued During Period Value In Warrant Exercise Transaction StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction	8712000	usd
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	408000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13846000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	16378000	usd
CY2021	chek	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction	22000	usd
CY2021	chek	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	19219000	usd
CY2021Q2	chek	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction	3199000	usd
CY2021	chek	Stock And Warrant Issued During Period Value In Registered Direct Offering Two StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo	31801000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	491000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50691000	usd
CY2022Q1	chek	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction	1150000	usd
CY2022	chek	Stock And Warrant Issued During Period Value In Registered Direct Offering Two StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo	8850000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	879000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41312000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13846000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	404000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	205000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	148000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	879000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	491000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	408000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	624000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-273000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	549000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-106000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	207000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	362000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-317000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-700000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	451000	usd
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	409000	usd
CY2022	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-38000	usd
CY2021	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-22000	usd
CY2020	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-28000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18707000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16264000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13113000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	486000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1006000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	379000	usd
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	12022000	usd
CY2021	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	15000000	usd
CY2020	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	10072000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12508000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16006000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10451000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	19219000	usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	chek	Proceeds From Issuance Resistered Direct Offering ProceedsFromIssuanceResisteredDirectOffering	8850000	usd
CY2021	chek	Proceeds From Issuance Resistered Direct Offering ProceedsFromIssuanceResisteredDirectOffering	31801000	usd
CY2020	chek	Proceeds From Issuance Resistered Direct Offering ProceedsFromIssuanceResisteredDirectOffering	10139000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8712000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4731000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8850000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	51024000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23582000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22365000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18754000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8053000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8035000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4442000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8053000	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	35000	usd
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	161000	usd
CY2020	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	45000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	307000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1048000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	151000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	33000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	548000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	62000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	54000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4090000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26457000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7703000	usd
CY2022Q4	chek	Restricted Cash Included Current Assets RestrictedCashIncludedCurrentAssets	352000	usd
CY2021Q4	chek	Restricted Cash Included Current Assets RestrictedCashIncludedCurrentAssets	350000	usd
CY2020Q4	chek	Restricted Cash Included Current Assets RestrictedCashIncludedCurrentAssets	350000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4442000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26807000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8053000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127293000	usd
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 10 to 1 for 20
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.4
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	48
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	223000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	150000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	579000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:20pt"> </td> <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td> <td style="vertical-align:top;text-align:justify;width:auto"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates in preparation of financial statements</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</span></span></div> </div>
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	839000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84626	shares
CY2022	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div> <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:20pt"> </td> <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F.</span></span></td> <td style="vertical-align:top;text-align:justify;width:auto"> <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash flow hedges</span></span></div> </td> </tr> </table> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.</span></span></div> <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"> </div> <div/> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264 and $3,466, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company’s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $56 and an asset, net, of $65, respectively and is included in other current liabilities and other current assets, respectively.</span></span></div> </div>
CY2022Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	5264000	usd
CY2021Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	3466000	usd
CY2022Q4	chek	Fair Value Of Hedging Option FairValueOfHedgingOption	56000	usd
CY2021Q4	chek	Fair Value Of Hedging Option FairValueOfHedgingOption	65000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	10.184
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	352000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	350000	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div> <div style="line-height:1.25"> </div> <div> <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"> <tr style="vertical-align:top"> <td style="width:20pt"> </td> <td style="vertical-align:top;width:29pt"> <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Q.</span></span></div> </td> <td style="vertical-align:top;width:auto"> <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassification</span></span></div> </td> </tr> </table> </div> <div style="line-height:1.25"> </div> <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders’ deficit, net loss or net cash used in operating activities.</span></span></div> </div>
CY2022Q4	chek	Government Institutional Assets Current GovernmentInstitutionalAssetsCurrent	88000	usd
CY2021Q4	chek	Government Institutional Assets Current GovernmentInstitutionalAssetsCurrent	206000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	260000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	470000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	8000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	13000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3288000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2984000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1537000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1191000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1751000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1793000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	346000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	205000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	148000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1060000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	964000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	389000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.044
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	352000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	282000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	410000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1044000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	80000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	964000	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	529000	usd
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	573000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	732000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1388000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1261000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1961000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	24232000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	24677000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24232000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24677000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	chek	Royalties Provision RoyaltiesProvision	94000	usd
CY2021Q4	chek	Royalties Provision RoyaltiesProvision	132000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84626	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	975000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	491000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	408000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	145895	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.2
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58239	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.75
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	12242	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	59.07
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	191892	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.35
CY2022	chek	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Three SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree	P8Y7M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	55259	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	79.79
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M20D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	54516	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	95.3
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M26D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	99935	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	26
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8206	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	92.9
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	350	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	145895	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.2
CY2021	chek	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Three SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree	P9Y1M17D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	27037	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	154.3
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y10D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27456	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	204.8
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30832	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.4
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3772	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	196.6
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	54516	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	95.3
CY2020	chek	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Three SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree	P8Y8M26D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15486	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	282.8
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	chek	Schedule Of Research And Development Expenses Net ScheduleOfResearchAndDevelopmentExpensesNet	<table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> <div style="line-height:1.25;margin-left:20pt"> </div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> <div style="line-height:1.25"> </div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"> <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom" valign="bottom"> <div style="line-height:1.25"> </div> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="2" style="vertical-align:bottom" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,257</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,428</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,173</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">493</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">329</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Materials</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,258</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,020</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,792</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subcontractors and consultants</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,375</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">820</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,103</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">289</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">169</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost for registration of patents</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,681</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">861</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">488</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%" valign="bottom"> <div style="line-height:1.25"> </div> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,493</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,780</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less participation of the IIA</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(222</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div> </td> <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"> </td> </tr> <tr> <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"> <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total research and development expenses, net</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,271</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,349</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> </td> <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div> </td> <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"> </td> </tr> </table>
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1784000	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2042000	usd
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1698000	usd
CY2022	chek	Share Based Compensation Expense Income Allocated To General And Administrative Expense ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense	386000	usd
CY2021	chek	Share Based Compensation Expense Income Allocated To General And Administrative Expense ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense	162000	usd
CY2020	chek	Share Based Compensation Expense Income Allocated To General And Administrative Expense ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense	243000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1092000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	710000	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	574000	usd
CY2022	chek	Office Rent And Maintenance OfficeRentAndMaintenance	246000	usd
CY2021	chek	Office Rent And Maintenance OfficeRentAndMaintenance	172000	usd
CY2020	chek	Office Rent And Maintenance OfficeRentAndMaintenance	174000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	116000	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	36000	usd
CY2020	us-gaap	Depreciation Nonproduction DepreciationNonproduction	25000	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2139000	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1850000	usd
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1210000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5763000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4972000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3924000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1047000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	101000	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	69000	usd
CY2022	us-gaap	Interest Expense InterestExpense	12000	usd
CY2021	us-gaap	Interest Expense InterestExpense	13000	usd
CY2020	us-gaap	Interest Expense InterestExpense	12000	usd
CY2022	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	37000	usd
CY2021	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	22000	usd
CY2020	chek	Changes In Liability To Pay Royalties ChangesInLiabilityToPayRoyalties	28000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-43000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-121000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	52000	usd
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	926000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	119000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	86000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-19108000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-17202000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13846000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5671786	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5671786	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4159870	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4159870	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1537060	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1537060	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.37
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.37
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.14
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.14
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.01
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.01
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	58000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	61000	usd
CY2020	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	57000	usd

Files In Submission

Name	View Source	Status
chek-20221231_lab.xml	Edgar Link	unprocessable
chek-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
zk2329433_htm.xml	Edgar Link	completed
0001178913-23-001275-index-headers.html	Edgar Link	pending
0001178913-23-001275-index.html	Edgar Link	pending
0001178913-23-001275.txt	Edgar Link	pending
0001178913-23-001275-xbrl.zip	Edgar Link	pending
chek-20221231.xsd	Edgar Link	pending
chek-20221231_pre.xml	Edgar Link	unprocessable
chek-20221231_cal.xml	Edgar Link	unprocessable
exhibit_1-1.htm	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_15-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
image00002.jpg	Edgar Link	pending
image00014.jpg	Edgar Link	pending
image1.jpg	Edgar Link	pending
image10.jpg	Edgar Link	pending
image11.jpg	Edgar Link	pending
image12.jpg	Edgar Link	pending
image13.jpg	Edgar Link	pending
image3.jpg	Edgar Link	pending
image4.jpg	Edgar Link	pending
image5.jpg	Edgar Link	pending
image6.jpg	Edgar Link	pending
image7.jpg	Edgar Link	pending
image8.jpg	Edgar Link	pending
image9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2329433.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHEK
Check-Cap Ltd Stock $chek

2022 Q4 Form 20-F Financial Statement

#000117891323001275 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHEK Check-Cap Ltd Stock $chek

2022 Q4 Form 20-F Financial Statement

#000117891323001275 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHEK
Check-Cap Ltd Stock $chek